Epigenomics AG
Epigenomics AG acts as a holding company dedicated to managing its own assets and acquiring investments in companies focused on minimally invasive blood tests for cancer detection. The firm manages a portfolio of investments in Germany and abroad while also investing in other financial assets. Its primary focus remains on the development and commercialization of molecular diagnostic products for the early detection of cancer.
Diagnostics
Biotechnology
Investment Management
Funding summary
- Total raised
- €9.8M
- Funding rounds
- 2
Investors in Epigenomics AG
Investors on record for Epigenomics AG. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Epigenomics AG?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors